Movatterモバイル変換

[0]ホーム
URL:

AU2024219072A1 - Antigen-capturing nanoparticles and formulations for immunotherapy - Google Patents

Antigen-capturing nanoparticles and formulations for immunotherapy

Info

Publication number
AU2024219072A1
AU2024219072A1AU2024219072AAU2024219072AAU2024219072A1AU 2024219072 A1AU2024219072 A1AU 2024219072A1AU 2024219072 AAU2024219072 AAU 2024219072AAU 2024219072 AAU2024219072 AAU 2024219072AAU 2024219072 A1AU2024219072 A1AU 2024219072A1
Authority
AU
Australia
Prior art keywords
formulations
antigen
immunotherapy
capturing
acpns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2024219072A
Inventor
Dapeng Qian
Hong Ren
Sonke Svenson
Andrew Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Archimmune Therapeutics Inc
Original Assignee
Archimmune Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Archimmune Therapeutics IncfiledCriticalArchimmune Therapeutics Inc
Publication of AU2024219072A1publicationCriticalpatent/AU2024219072A1/en
Pendinglegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

The present invention provides novel antigen-capturing nano-particles (ACNPs) and pharmaceutical formulations containing such ACNPs. Also provided herein are methods for preparing the ACNP formulations, and methods for the treatment of a disease (such as cancer) in a subject with the ACPNs or a pharmaceutical formulation containing the ACPNs.
AU2024219072A2023-02-062024-02-06Antigen-capturing nanoparticles and formulations for immunotherapyPendingAU2024219072A1 (en)

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
US202363443555P2023-02-062023-02-06
US63/443,5552023-02-06
PCT/US2024/014664WO2024167958A1 (en)2023-02-062024-02-06Antigen-capturing nanoparticles and formulations for immunotherapy

Publications (1)

Publication NumberPublication Date
AU2024219072A1true AU2024219072A1 (en)2025-08-21

Family

ID=92263420

Family Applications (1)

Application NumberTitlePriority DateFiling Date
AU2024219072APendingAU2024219072A1 (en)2023-02-062024-02-06Antigen-capturing nanoparticles and formulations for immunotherapy

Country Status (4)

CountryLink
KR (1)KR20250141821A (en)
CN (1)CN120659602A (en)
AU (1)AU2024219072A1 (en)
WO (1)WO2024167958A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
TW200914437A (en)*2007-06-202009-04-01Ironwood Pharmaceuticals IncFAAH inhibitors
AU2010328336B2 (en)*2009-12-072017-03-02Arbutus Biopharma CorporationCompositions for nucleic acid delivery
US11446390B2 (en)*2015-11-182022-09-20The University Of North Carolina At Chapel HillAntigen capturing nanoparticles for use in cancer immunotherapy

Also Published As

Publication numberPublication date
CN120659602A (en)2025-09-16
KR20250141821A (en)2025-09-29
WO2024167958A1 (en)2024-08-15

Similar Documents

PublicationPublication DateTitle
Li et al.Burst release of encapsulated annexin A5 in tumours boosts cytotoxic T-cell responses by blocking the phagocytosis of apoptotic cells
Kung et al.Microwave assisted synthesis of negative-charge carbon dots with potential antibacterial activity against multi-drug resistant bacteria
MX2022004989A (en)Pharmaceutical compositions of albumin and rapamycin.
CA2386775A1 (en)Drugs for the treatment of malignant tumours
Sang et al.Remodeling macrophages by an iron nanotrap for tumor growth suppression
YU23202A (en)Drugs for the treatment of malignant tumors
Jindal et al.Nanomaterials-mediated immunomodulation for cancer therapeutics
MY136430A (en)N-adamantylmethyl derivatives, pharmaceutical compositions containing them and processes for their preparation
EP3741362A3 (en)Surface-modified mesoporous silica nanoparticle for blood-brain barrier penetration, tumor targeting and cancer metastasis treatment, methods of production and uses thereof
CA2298093A1 (en)An anti-cancer therapy agent of arsenic hexoxide (as4o6) of a natural chemical substance and its pharmaceutical composition
Kim et al.Injectable hydrogel-based combination cancer immunotherapy for overcoming localized therapeutic efficacy
Sabir et al.Development and characterization of n-propyl gallate encapsulated solid lipid nanoparticles-loaded hydrogel for intranasal delivery
EP4295917A3 (en)Trans-cyclooctene bioorthogonal agents and uses in cancer and immunotherapy
WO2018038988A3 (en)Imidazo[1,2-a]pyridin compounds, compositions comprising them, methods for treating diseases using them, and methods for preparing them
Fernandes et al.Metal-organic frameworks applications in synergistic cancer photo-immunotherapy
Cabral et al.Pluronic F-127 hydrogels containing copper oxide nanoparticles and a nitric oxide donor to treat skin cancer
EP1594885B8 (en)Medicament for inhibiting tumour growth
AU2024219072A1 (en)Antigen-capturing nanoparticles and formulations for immunotherapy
Shereen Farhana et al.Synthesis and characterization of zirconium oxide nanoparticles based on Hemidesmus indicus extract: Evaluation of biocompatibility and bioactivity for prosthetic implant coatings
Dilfy et al.Optimizing chrysin’s anticancer efficacy on MDA-MB-231 cells: synthesis and characterization of chrysin-loaded gold/chitosan nanoparticles
AU2024210274A1 (en)Drug conjugates and methods of preparing and using the same
Vieira et al.An engineered POSS drug delivery system for copper (ii) anticancer metallodrugs in a selective application toward melanoma cells
WO2022241331A3 (en)Polymer-lipid hybrid nanoparticles of emricasan and use thereof
AU7599900A (en)Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles
FotieApplications of Tailored Mesoporous Silicate Nanomaterials in Regenerative Medicine and Theranostics
[8]ページ先頭
©2009-2025 Movatter.jp